Portal de Periódicos da CAPES

The Role of Peptide Specificity in MHC Class I‐Restricted Allogeneic Responses

1996; Wiley; Volume: 154; Issue: 1 Linguagem: Inglês

10.1111/j.1600-065x.1996.tb00929.x

1600-065X

Jeffrey A. Frelinger, Minnie Mc Millan,

T-cell and B-cell Immunology

Immunological ReviewsVolume 154, Issue 1 p. 45-58 The Role of Peptide Specificity in MHC Class I-Restricted Allogeneic Responses Jeffrey A. Frelinger, Jeffrey A. Frelinger Department of Microbiology and Immunology, University of North Carolina. Chapel Hill NC 27599-7290 and Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.Search for more papers by this authorMinnie Mc Millan, Minnie Mc Millan Department of Microbiology and Immunology, University of North Carolina. Chapel Hill NC 27599-7290 and Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.Search for more papers by this author Jeffrey A. Frelinger, Jeffrey A. Frelinger Department of Microbiology and Immunology, University of North Carolina. Chapel Hill NC 27599-7290 and Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.Search for more papers by this authorMinnie Mc Millan, Minnie Mc Millan Department of Microbiology and Immunology, University of North Carolina. Chapel Hill NC 27599-7290 and Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.Search for more papers by this author First published: December 1996 https://doi.org/10.1111/j.1600-065X.1996.tb00929.xCitations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Alexander, J., Payne, J., Murray, R., Frelinger, J. & Cresswell, P. (1989) Differential transport requirements of HLA and H-2 class I glycoproteins. Immunonenetics 29(6), 380. Alexander, J., Payne, J. A., Shigekawa, B., Frelinger, J. & Cresswell, P. (1990). The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains. Immunogenetics 31(3), 169. Alexander-Miller, M., Burke, K., Kozinowski, O. & Hansen, T. (1993) Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite pep-tide and MHC specificity. J. Immunol. 151(1), 1. Berke, G. (1994). The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12, 735. Bjorkman, P. J. & Davis, M. M. (1989). Model for the interaction of T-cell receptors with peptide/MHC complexes. Cold Spring Harbor Symp. Quant. Biol. 54(1), 365. Blake, J., Johnstone J., Hellstrom, K., Marquardt, H. & Chen, L. (1996). Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T-lymphocytes. J. Exp. Med. 184, 121. Bluestone, J. A., Kaliyaperumal, A., Jameson, S., Miller, S. & Dick, R. (1993). Peptide-induced changes in class I heavy chains alter allorecognition. J. Immunol. 151(8), 3943. Catipovic, B., Talluri G., Oh, J., Wei, T., Su, X., Johansen, T., Ettitun, M. & Schneck, J. (1994). Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface. J. Exp. Med. 180(5), 1753. Chattopadhyay, S., Theobald, M., Biggs, J. & Sherman, L. (1994) Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 179(1), 213. Chen, Y., Sidney J., Southwood, S., Cox, A., Sakaguchi, K., Henderson, R., Appella, E., Hunt, D., Sette, A. & Engelhard, V. (1994). Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152(6). 2874. Esquivel, F., Yewdell J., & Bennick, J. (1992). RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175(1), 163. Gavin, M. A., Dere B., Grandea, A., Hogquist, K. & Bevan, M. (1994). Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope. Eur. J. Immunol. 24(9). 2124. Golstein, P., Ojcius D. M. & Young, J. (1991). Cell death mechanisms and the immune system. Immunol. Rev. 121, 29. Gorer, P, Lyman S. & Snell, G. (1948). Studies on the genetic and antigenic basis of tumor transplantation. Linkage between a histocompatibility gene and fused in mice. Proc, R. Soc. BI35, 99. Hao, L. M., Wang Y., Gill, R., La Rosa, F., Talmage, D & Laffery, K. (1990). Role of lymphokine in islet allograft rejection. Transplantation 49(3), 609. Hasenkrug, K. J., Kesari K. V. & Nathenson, S. (1992). Unique biochemical properties of a mutant MHC class I molecule. H-2Ksml. Mol. Immunol. 29(12), 1493. Heath, W. R., Hurd M. E., Murray, R., Frelinger, J. & Sherman, L. (1990) Analysis of novel residues of class I involved in recognition by alloreactive T cells) Immunogenetics 32(2), 138. Henderson, R. A., Cox A. L., Sakaguchi, K., Appella, E., Shabanowitz, J., Hunt, D. & Engelhard, V. (1993). Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc. Natl. Acad, Sci U. S. A. 90(21), 10275. Hunt, D. F., Henderson R. A. Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A., Appella, E. & Engelhard, V. (1992). Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry Science 255(5049), 1261. Kageyama, S., Tsomides T. J., Sykulev, Y. & Eisen, H. (1995). Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154(2), 567. Killion, C., Chen, P., Dadgari, J. & McMillan, M. (1995). Dissection of cross-reactivities using a panel of H-2Lb alloreactive T cell hybridomas. Cell. Immunol. 164, 81. Klein, J. (1986) Natural History of the Major Histocompatibility Complex, Wiley-Interscience. New York . Louie, K., Ochoa-Garay, J., Chen, R., McKinney, D., Groshen, S. & McMillan, M. (1996). H-2Lb-alloreactive T cell hybridomas utilize diverse Vα and Vβ T cell receptor chains. Mol. Immunol. 33(9), 747. McMichael, A. J., Askonas B. & Frelinger, J. (1991). Class I antigen processing and presentation. In: Antigen Processing and Recognition (ed. J. McClusky); p. 85. CRC Press, Boca Raton . Matsui, M., Hioe C. E. & Frelinger, J. (1993). Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc. Natl. Acad. Sci. U. S. A. 90(2), 674. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991. Moots, R. J., Matsui M., Pazmany, L., Freiinger, J. & McMichael, A. (1991). A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells. Immunogenetics 34(3), 141. Mosmann, T. R. & Coffman, R. L. (1989). Th1 and Th2 cells: difTerent patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145. Muller, D., Pederson, K., Murray, R. & Frelinger, J. (1991). A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes. J. Immunol. 147(4), 1392. Murray, R., Hutchison A. & Frelinger, J. (1988a). Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition. Proc. Natl. Acad, Sci, U. S. A. 85, 3535. Murray, R., Pederson, K., Hutchison, C. & Frelinger, J. (1988b). Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2Dp. Nucleic Acids Res. 16(20), 9761. Peace-Brewer, A., Tussey L., Matsui, M., Li, G., Quinn, D. & Frelinger, J. (1996). A point mutation in HLAA*0210 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4, 505. Pogue, R. R., Eron, J., Frelinger, J. & Matsui, M. (1995). Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. U. S. A. 92(18). 8166. Pullen, J. K., Tallquist M. D., Metvolt, R. & Pease, L. (1994). Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide. J. Immunol. 152(7), 3445. Sad, S., Marcotte R. & Mosmann, T. (1995). Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CDS T cells secreting Thl or Th2 cytokines. Immunity 2(3), 271. Sadasivan, B., Lehner P., Ortmann, B., Spies, T. & Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with transporters associated with antigen processing (TAP). Immunity 5, in press. Schirmbeck, R., Deppert, W., Kury, E. & Reimann, J. (1993). In vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations. Cell. Immunol. 149(2). 444. Smith, K., Reid S., Harlos, K., McMichael, A., Stuart, D., Bell, J. & Jones, E. (1966). Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4, 215. Sredni, B. & Schwartz, R. H. (1980). Alloreactivity of an antigen-specific T-cell clone. Nature 287(5785), 855. Sredni, B. & Schwartz, R. H. (1981). Antigen-specific, proliferating T lymphocyte clones. Methodology, specificity. MHC restriction and alloreactivity, Immunol. Rev. 54, 1 87. Sykulev, Y., Brunmark A., Tsomides, T., Kageyama, S., Jackson, M., Peterson, P. & Eisen, H. (1994). High-affinity REACTIONS between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci U. S. A. 91(24), 11487. Tjoa, B. A. & Kranz, D. M. (1994). Sequence restrictions in T cell receptor beta-chains that have specificity for a self-peptide/Ld complex. Mol. Immunol. 31 (10), 705. Tough, D. Borrow. P & Sprent, J. (1996). Induction of bystander T cell proliferation by viruses and type I interferon. Science 111, 111. Tussey, L. G., Matsui, M., Rowland-Jones, S., Warburton, R., Frelinger, J. & McMichael, A. (1994). Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition. J. Immunol. 152(3), 1213. Viola, A. & Lanzavecchia, A. (1996). T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104. Wucherpfennig, K. W. & Strominger, J. L. (1995). Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80(5). 695. Zinkernagel, R. & Doherty, P (1979). MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv. Immunol. 27: 51. Zweerink, H. J., Gammon M. C., Utz, U, Sauma, Y., Harrer, T., Hawkins, J. et al. (1993) Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150(5), 1763. Citing Literature Volume154, Issue1December 1996Pages 45-58 ReferencesRelatedInformation